Hygeia Therapeutics Obtains $1,000,000 Series A Round

  • Feed Type
  • Date
  • Company Name
    Hygeia Therapeutics
  • Mailing Address
    8 Canterbury Lane Holden Holden, MA 01520
  • Company Description
    Hygeia Therapeutics acquires and develops biodegradable
    hormone-receptor modulators for topical indications.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
    Series A
  • Proceeds Purposes
    The funding will go to testing its topical synthetic estrogen drug designed to treat age-related skin thinning, and will fuel the development of a topical anti-androgen drug.
  • M&A Terms
  • Venture Investor

Trending on Xconomy